Clinical Trials Browser

Phase 1/2 × Bone Diseases, Metabolic × Breast × Clear all

NCT03518268 2019-01-17

Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor

Phase 1/2 Unknown

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis